Results 141 to 150 of about 939 (187)

Chronic Migraine Resistance: A Case Report Highlights an Overlooked Factors in Family Medicine Clinics. [PDF]

Healthcare (Basel)
Alshareef MH.
europepmc   +1 more source

Genetic migraine disorders and the response to calcitonin gene-related peptide antagonist treatment. [PDF]

Headache
Kuczynski AM, Kingston WS.
europepmc   +1 more source

Safety and Effectiveness of Pain Medications for Migraine Management During Pregnancy and Lactation. [PDF]

Paediatr Drugs
Smirnoff L, Mancera NG, Hyppolite T, Lozano D, Cocores A.   +4 more
europepmc   +1 more source

Pharmacokinetics of Atogepant in Healthy Lactating Female Participants: Results from a Phase 1 Lactation Study. [PDF]

Neurol Ther
Boinpally RR, Smith JH, De Abreu Ferreira RL, Trugman JM.   +3 more
europepmc   +1 more source

Innovative treatments for migraine: a new era. [PDF]

Ther Adv Neurol Disord
Pistoia F.
europepmc   +1 more source

Sex-specific considerations in migraine therapy. [PDF]

Neurotherapeutics
Rubio-Beltran E, MaassenVanDenBrink A.
europepmc   +1 more source

The impact of headache specialist density and the introduction of gepants and lasmitidan on prescriptions for acute migraine treatments: a regression and interrupted time series analysis. [PDF]

Front Neurol
Moskatel LS, Linfield RY, Zhang N.
europepmc   +1 more source

Sex-specific management of migraine a systematic review and consensus statement from the European Headache Federation (EHF). [PDF]

J Headache Pain
Braca S, Casillo F, Moreira S, Ekizoglu E, Bjork MH, Szewczyk AK, Van Dycke A, Uluduz D, Coppola G, Deligianni C, Lampl C, Tronvik E, Amin FM, Versijpt J, Ryliškienė K, Rio MSD, Holland PR, Terwindt G, Reuter U, MaassenVanDenBrink A, Gil-Gouveia R.   +20 more
europepmc   +1 more source

Gepants in Primary Care: A Targeted Approach to Acute and Preventive Treatment of Migraine. [PDF]

Pain Ther
Moriarty MA, Barch CA.
europepmc   +1 more source